セッション情報

International Symposium

第52回・2014年・横浜
International Symposium
International Symposium 04
The Future of Cancer Therapy -Translational Approaches Targeting for Anti-cancer Therapy-
開催回
第52回・2014年・横浜

Development of monoclonal antibody (Mogamulizumab) as a drug for ATL patients

演題番号 : TIS4-1

Ueda Ryuzo:1

1:Department of Tumor Immunology, School of Medicine, Aichi Medical University

Development of monoclonal antibody (Mogamulizumab) as a drug for ATL patients

Recent Advances in The Strategy for Clinical Research in Childhood Cancer in Japan (JCCG)

演題番号 : TIS4-2

Mizutani Shuki:1、Nakagawara Akira:2、Fukuzawa Masahiro:3、Adachi Soichi:4

1:Dept. of Pediatrics, Tokyo Medical and Dental University、2:Chiba Cancer Center、3:Osaka Medical Center and Research Institute for Maternal and Child Health、4:Human Health Sciences, Graduate School of Medicine, Kyoto University

Recent Advances in The Strategy for Clinical Research in Childhood Cancer in Japan (JCCG)

An Accelerated Comprehensive Strategy to Fight Triple-Negative Breast Cancer Under the Moon Shots Program

演題番号 : TIS4-3

Ueno Naoto T.:1

1:Division of Cancer Medicine, Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, U.S.A.

An Accelerated Comprehensive Strategy to Fight Triple-Negative Breast Cancer Under the Moon Shots Program

The Future of Cancer Therapy: Translational Approaches To Targeting For Anti-cancer Therapy

演題番号 : TIS4-4

Takebe Naoko:1

1:Cancer Therapy Evaluation Program(CTEP), Division of Cancer Treatment and Diagnosis, NIH/NCI, U.S.A.

The Future of Cancer Therapy: Translational Approaches To Targeting For Anti-cancer Therapy

Current Actions of PMDA for New Drug Development of Japan Origin

演題番号 : TIS4-5

Yamori Takao:1

1:Director of Center for Product Evaluation, Pharmaceuticals and Medical Devices Agency(PMDA)

Current Actions of PMDA for New Drug Development of Japan Origin